Fast Market Research recommends "Saladax Biomedical, Inc. - Product Pipeline Analysis, 2013 Update" from GlobalData, now available

Boston, MA -- (SBWire) -- 06/07/2013 --Saladax Biomedical, Inc. (Saladax) is a healthcare diagnostics company. The company develops and commercializes diagnostic assays for the practical delivery of personalized medicine. Its products include 5-Fluorouacil, dotacexel, paclitaxel, cyclophosphamide, irinotecan, busulfan, lenalidomide, doxorubicin, thalidomide, imatinib myselate, tyrosine kinase inhib, gemicitabine, risperidone, vincristine and clozapine. The company focuses on oncology drug dose optimization, with a portfolio of thirteen proprietary cancer drug assays and two in anti-psychotics in various stages of development. Saladax is ISO 13485:2003 certified. It partners with AB Analitica, FALCO Biosystems, Genoxa, Kaan Med, Myriad and others. Saladax is headquartered in Bethlehem, Pennsylvania, the US.

View Full Report Details and Table of Contents

This report is a source for data, analysis and actionable intelligence on the Saladax Biomedical, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get This Report

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.

Companies Mentioned in this Report: Saladax Biomedical, Inc.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- Hycor Biomedical Inc. - Product Pipeline Analysis, 2013 Update
- Beckman Coulter, Inc. - Product Pipeline Analysis, 2013 Update
- Biotronik SE & Co. KG - Product Pipeline Analysis, 2013 Update
- Sequenom, Inc. (SQNM) - Product Pipeline Analysis, 2013 Update
- GE Healthcare - Product Pipeline Analysis , 2013 Update
- TiGenix NV (TIG) - Product Pipeline Analysis, 2013 Update
- Philips Healthcare - Product Pipeline Analysis, 2013 Update
- BioTex, Inc. - Product Pipeline Analysis, 2013 Update
- Kensey Nash Corporation - Product Pipeline Analysis, 2013 Update
- Boston Scientific Corporation (BSX) - Product Pipeline Analysis, 2013 Update